Aiham Albaeni1, Khaled Chatila2, Hind A Beydoun3, May A Beydoun4, Mohammad Morsy2, Wissam I Khalife2. 1. Department of Medicine, University of Central Florida, Ocala, FL, United States of America. Electronic address: aialbaen@utmb.edu. 2. Department of Medicine, Division of Cardiology, University of Texas Medical branch, Galveston, TX, United States of America. 3. Division of Research Programs, Office of Education Training and Research, Fort Belvoir Community Hospital, Fort Belvoir, VA. 4. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD, United States of America.
Abstract
BACKGROUND: In-hospital left ventricular (LV) thrombus following acute ST-elevation myocardial infarction (STEMI) has not been evaluated on a national scale and was the focus of this investigation. METHODS: We used the 2003 to 2013 Nationwide Inpatient Sample database to identify adults ≥18 years old with a principal diagnosis code of ST-elevation myocardial infarction. Patients were divided into two groups defined by the presence or absence of LV thrombus. Clinical characteristics and in-hospital outcomes were studied using relevant statistics. Multiple linear and logistic regression models were conducted to identify factors associated with LV thrombus. RESULTS: Of 1,035,888 STEMI patients hospitalized in the U. S from 2003 to 2013, 1982 (0.2%) developed acute in-hospital LV thrombus. Compared to no LV thrombus, patients with LV thrombus were more likely to have in-hospital complications; acute ischemic and hemorrhagic stroke, acute renal failure, gastrointestinal bleed, cardiogenic shock, in-hospital cardiac arrest and mortality. They also had longer mean length of stay and higher hospital charges. Factors associated with LV thrombus included: anterior/anterolateral STEMI, acute or chronic heart failure with reduced ejection fraction, atrial fibrillation, LV aneurysm, Left heart valvular disease, acute or chronic deep venous thrombosis/pulmonary embolism and alcohol abuse. Patients with LV thrombus were less likely to be female [AOR 0.66, 95% CI (0.51-0.84)]. CONCLUSION: The identification of factors associated with early development of LV thrombus following STEMI, will help direct resources for specific high-risk group and prompt cost-effective therapies. Gender variability in LV thrombus development warrants further investigations.
BACKGROUND: In-hospital left ventricular (LV) thrombus following acute ST-elevation myocardial infarction (STEMI) has not been evaluated on a national scale and was the focus of this investigation. METHODS: We used the 2003 to 2013 Nationwide Inpatient Sample database to identify adults ≥18 years old with a principal diagnosis code of ST-elevation myocardial infarction. Patients were divided into two groups defined by the presence or absence of LV thrombus. Clinical characteristics and in-hospital outcomes were studied using relevant statistics. Multiple linear and logistic regression models were conducted to identify factors associated with LV thrombus. RESULTS: Of 1,035,888 STEMI patients hospitalized in the U. S from 2003 to 2013, 1982 (0.2%) developed acute in-hospital LV thrombus. Compared to no LV thrombus, patients with LV thrombus were more likely to have in-hospital complications; acute ischemic and hemorrhagic stroke, acute renal failure, gastrointestinal bleed, cardiogenic shock, in-hospital cardiac arrest and mortality. They also had longer mean length of stay and higher hospital charges. Factors associated with LV thrombus included: anterior/anterolateral STEMI, acute or chronic heart failure with reduced ejection fraction, atrial fibrillation, LV aneurysm, Left heart valvular disease, acute or chronic deep venous thrombosis/pulmonary embolism and alcohol abuse. Patients with LV thrombus were less likely to be female [AOR 0.66, 95% CI (0.51-0.84)]. CONCLUSION: The identification of factors associated with early development of LV thrombus following STEMI, will help direct resources for specific high-risk group and prompt cost-effective therapies. Gender variability in LV thrombus development warrants further investigations.
Authors: Sahil Khera; Dhaval Kolte; Tanush Gupta; Kathir Selvan Subramanian; Neel Khanna; Wilbert S Aronow; Chul Ahn; Robert J Timmermans; Howard A Cooper; Gregg C Fonarow; William H Frishman; Julio A Panza; Deepak L Bhatt Journal: J Am Coll Cardiol Date: 2015-11-03 Impact factor: 24.094
Authors: Esther Cambronero-Cortinas; Clara Bonanad; Jose V Monmeneu; María Pilar Lopez-Lereu; Jose Gavara; Elena de Dios; Cesar Rios; Nerea Perez; Paolo Racugno; Ana Paya; David Escribano; Gema Minana; Mauricio Pellicer; Joaquim Cànoves; Julio Nunez; Francisco J Chorro; David Moratal; Vicente Bodi Journal: Radiology Date: 2017-03-02 Impact factor: 11.105
Authors: Megan E Bass; Tyree H Kiser; Robert L Page; Colleen K McIlvennan; Larry A Allen; Garth Wright; Courtney Shakowski Journal: J Thromb Thrombolysis Date: 2021-01-09 Impact factor: 2.300
Authors: Ramez Alyacoub; Sherif Elkattawy; Shruti Jesani; Carlos Perez Hernandez; Hardik Fichadiya; Muhammad Atif Masood Noori; Omar Elkattawy; Edward Williams Journal: Eur J Case Rep Intern Med Date: 2022-06-23